Seeing Is Believing
TSHA is currently covered by 15 analysts with an average price target of $10.01. This is a potential upside of $7.66 (325.96%) from yesterday's end of day stock price of $2.35.
Taysha Gene Therapies 's activity chart (see below) currently has 32 price targets and 73 ratings on display. The stock rating distribution of TSHA is 95.45% BUY and 4.55% HOLD.
Analysts average stock forecasts to be materialized ratio is 15.56% with an average time for these price targets to be met of 57.33 days.
Highest price target for TSHA is $7, Lowest price target is $4, average price target is $10.01.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 19-Apr-2024. First documented stock forecast 19-Oct-2020.
Currently out of the existing stock ratings of TSHA, 42 are a BUY (95.45%), 2 are a HOLD (4.55%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$4.65 (197.87%)
7
6 days ago
1/6 (16.67%)
$4.73 (208.37%)
137
Buy
7
$4.65 (197.87%)
5
14 days ago
0/6 (0%)
$3.78 (117.39%)
Buy
5
$2.65 (112.77%)
5
5 months 10 days ago
0/4 (0%)
$3.32 (197.62%)
Buy
7
$4.65 (197.87%)
8
5 months 10 days ago
0/4 (0%)
$5.32 (316.67%)
Buy
6
$3.65 (155.32%)
7
7 months 5 days ago
0/2 (0%)
$2.94 (96.08%)
What is TSHA (Taysha Gene Therapies ) average time for price targets to be met?
Which analyst has the current highest performing score on TSHA (Taysha Gene Therapies ) with a proven track record?
Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies )?
Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies )?
Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies )?